Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Adult Primary Hepatocellular Carcinoma: early-phase trial registry

A small indexed set (6 trials) with no open enrollment listed right now.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count

Adult Primary Hepatocellular Carcinoma: 6 US clinical trials tracked, none currently recruiting.

Adult Primary Hepatocellular Carcinoma is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 4 of these trials.

Enrollment posture brief

Registry condition adult-primary-hepatocellular-carcinoma

OPEN 0 | RECR 0% | LATE 0 | EARLY 6 | RANK #2866 | SPON 4

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Adult Primary Hepatocell (th…0%
Open-enrollment share among volume-matched conditions near Adult Primary Hepatocellular Carcinoma

Adult Primary Hepatocellular Carcinoma has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adult Primary Hepatocellular Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adult Primary Hepatocellular Carcinoma is recruiting below its size-band peers.

    0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Adult Primary Hepatocellular Carcinoma research.

    National Cancer Institute (NCI) accounts for 4 of 6 trials (66.7%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Most Adult Primary Hepatocellular Carcinoma trials plan to enrol fewer than 100 people.

    Median target enrolment is 26 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Adult Primary Hepatocellular Carcinoma research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 14Phase 22

Phase Distribution

PhaseTrial count
Phase 1 4
Phase 2 2

Top Sponsors

National Cancer Institute (NCI) 4 trials
University of Washington 1 trials
City of Hope Medical Center 1 trials

Named interventions

Most-linked intervention names on Adult Primary Hepatocellular Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

laboratory biomarker analysis Other
4 trials
sorafenib tosylate Drug
2 trials
pharmacological study Other
2 trials
recombinant fowlpox-CEA(6D)/TRICOM vaccine Biological
1 trials
recombinant fowlpox GM-CSF vaccine adjuvant Biological
1 trials
Chinese herbal formulation PHY906 Dietary supplement
1 trials
erlotinib hydrochloride Drug
1 trials
lapatinib ditosylate Drug
1 trials

US sites by state

Facility locations filed on Adult Primary Hepatocellular Carcinoma trials. A trial with sites in several states counts in each.

Washington 1 trials
Texas 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Adult Primary Hepatocellular Carcinoma page

6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Adult Primary Hepatocellular Carcinoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • National Cancer Institute (NCI) sponsors the most Adult Primary Hepatocellular Carcinoma trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adult Primary Hepatocellular Carcinoma condition card totals 6 registered trials; most-linked intervention laboratory biomarker analysis; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.